Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers. - Emadali A; Rousseaux S; Bruder-Costa J; Rome C; Duley S; Hamaidia S; Betton P; Debernardi A; Leroux D; Bernay B; Kieffer-Jaquinod S; Combes F; et al. (EMBO molecular medicine, 2013)